Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SHE:300204)
China · Delayed Price · Currency is CNY 30.33
-1.18 (-3.74%)
Apr 17, 2026, 3:10 PM CST
SHE:300204 Market Cap
SHE:300204 has a market cap or net worth of 14.49 billion as of April 17, 2026. Its market cap has increased by 296.47% in one year.
Market Cap
14.49B
Enterprise Value
14.36B
Revenue
244.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
30.33
Market Cap Chart
Since April 15, 2011, SHE:300204's market cap has increased from 3.33B to 14.49B, an increase of 335.51%. That is a compound annual growth rate of 10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 14.49B | 11.02% |
| Dec 31, 2025 | 13.05B | 268.69% |
| Dec 31, 2024 | 3.54B | -27.07% |
| Dec 29, 2023 | 4.85B | -24.38% |
| Dec 30, 2022 | 6.42B | -22.12% |
| Dec 31, 2021 | 8.24B | 94.35% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anhui Anke Biotechnology (Group) | 16.60B |
| Jinyu Bio-technology | 16.19B |
| Mabwell (Shanghai) Bioscience | 16.00B |
| Inner Mongolia Furui Medical Science | 15.05B |
| Tibet Cheezheng Tibetan Medicine | 13.35B |
| InventisBio | 13.09B |
| Vcanbio Cell & Gene Engineering Corp., | 13.07B |
| Chengzhi | 12.86B |